We are live on ! Find out more
KYTH

KYTHERA BIOPHARMACEUTICALS, INC COM
KYTH

Delisted

KYTH was delisted on the 30th of September, 2015.

Back to rankings

106 hedge funds and large institutions have $663M invested in KYTHERA BIOPHARMACEUTICALS, INC COM in 2014 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 36 increasing their positions, 34 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 1 → 2 (+1)

5% more capital invested

Capital invested by funds: $631M → $663M (+$31.9M)

6% more repeat investments, than reductions

Existing positions increased: 36 | Existing positions reduced: 34

4% less funds holding

Funds holding: 110 → 106 (-4)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

84% less call options, than puts

Call options by funds: $482K | Put options by funds: $2.99M

Holders
106
Holders Change
-4
Holders Change %
-3.64%
% of All Funds
2.83%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
16
Increased
36
Reduced
34
Closed
18
Calls
$482K
Puts
$2.99M
Net Calls
-$2.51M
Net Calls Change
-$523K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$25.2M
2
TAM
Tocqueville Asset Management
New York
+$6.63M
3
BFA
BlackRock Fund Advisors
California
+$3.82M
4
Allianz Asset Management
Allianz Asset Management
Germany
+$3.72M
5
PHS
PFM Health Sciences
California
+$3.72M

Top Sellers

Rank Fund Capital Flow
1
Massachusetts Financial Services
Massachusetts Financial Services
Massachusetts
-$12.4M
2
WRF
Waddell & Reed Financial
Kansas
-$10.8M
3
RG
Redmile Group
California
-$9.22M
4
Jennison Associates
Jennison Associates
New York
-$8.32M
5
AGA
Altrinsic Global Advisors
Connecticut
-$5.18M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCA
101
Mercer Capital Advisers
New Jersey
$10K +$10.5K +300 New
LTFS
102
Ladenburg Thalmann Financial Services
Florida
$7K – – –
PNC Financial Services Group
103
PNC Financial Services Group
Pennsylvania
$2K – – –
IPC
104
Independent Portfolio Consultants
Florida
$2K +$1.57K +45 New
BPBT
105
Boston Private Bank & Trust
Massachusetts
$1K +$1.05K +30 New
Manulife (Manufacturers Life Insurance)
106
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$400 -$10.4K -297 -3%
RG
107
Redmile Group
California
– -$9.22M -281,479 Closed
AGA
108
Altrinsic Global Advisors
Connecticut
– -$5.18M -158,154 Closed
Lord, Abbett & Co
109
Lord, Abbett & Co
New Jersey
– -$3.01M -91,960 Closed
GC
110
Guggenheim Capital
Illinois
– -$2.29M -69,856 Closed
SAM
111
Senzar Asset Management
New York
– -$2.17M -66,300 Closed
SM
112
Senvest Management
New York
– -$1.73M -52,787 Closed
Alyeska Investment Group
113
Alyeska Investment Group
Illinois
– -$928K -28,342 Closed
GACM
114
Green Arrow Capital Management
New York
– -$655K -20,000 Closed
Mackenzie Financial
115
Mackenzie Financial
Ontario, Canada
– -$619K -18,897 Closed
CCI
116
Columbus Circle Investors
– -$467K -14,242 Closed
PAM
117
Paradigm Asset Management
New York
– -$308K -9,400 Closed
PP
118
PDT Partners
New York
– -$216K -6,600 Closed
Citadel Advisors
119
Citadel Advisors
Florida
– -$217K -6,216 Closed
BF
120
BOK Financial
Oklahoma
– -$128K -3,894 Closed
SO
121
STRS Ohio
Ohio
– -$49K -1,492 Closed
Millennium Management
122
Millennium Management
New York
– -$47.2K -1,353 Closed
BNP Paribas Financial Markets
123
BNP Paribas Financial Markets
France
– -$33.8K -1,031 Closed
TRCT
124
Tower Research Capital (TRC)
New York
– -$13K -388 Closed
1 2 3 4
5

KYTH Hedge Fund Activity: Q4 2014 in Review

106 of the 3,750 institutional investors tracked by Wall St. Rank reported a position in KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) for Q4 2014, worth a combined $663M — up 5.1% from $631M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of KYTH and 16 opened new positions — a net loss of 2 holders — while 34 trimmed existing stakes and 36 added.

The largest buyer was OrbiMed, opening a new position worth an estimated $25.2M. The largest seller was Massachusetts Financial Services, cutting an estimated $12.4M.

  • 106 institutional investors held KYTHERA BIOPHARMACEUTICALS, INC COM (KYTH) as of Q4 2014, down from 110 in Q3 2014.
  • Funds reported $663M of KYTHERA BIOPHARMACEUTICALS, INC COM stock for Q4 2014, up 5.1% quarter-over-quarter.
  • 16 funds opened new KYTHERA BIOPHARMACEUTICALS, INC COM positions in Q4 2014 and 18 closed out, a net change of -2 holders.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM buyer in Q4 2014 was OrbiMed, an estimated $25.2M added.
  • The largest KYTHERA BIOPHARMACEUTICALS, INC COM seller in Q4 2014 was Massachusetts Financial Services, an estimated $12.4M sold.

Based on aggregated 13F filings for Q4 2014.